Chemoinformaics analysis of BETA-CYMAROPYRANOSE
| Molecular Weight | 162.185 | nRot | 1 |
| Heavy Atom Molecular Weight | 148.073 | nRig | 6 |
| Exact Molecular Weight | 162.089 | nRing | 1 |
| Solubility: LogS | 0.616 | nHRing | 1 |
| Solubility: LogP | -0.835 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 24.2331 |
| nHD | 2 | BPOL | 17.5169 |
| QED | 0.545 |
| Synth | 3.89 |
| Natural Product Likeliness | 2.739 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.107 |
| HIA | 0.045 |
| CACO-2 | -4.909 |
| MDCK | 0.000518432 |
| BBB | 0.312 |
| PPB | 0.0915915 |
| VDSS | 1.433 |
| FU | 0.85618 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.4 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.834 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.128 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.284 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.206 |
| CL | 7.561 |
| T12 | 0.658 |
| hERG | 0.02 |
| Ames | 0.66 |
| ROA | 0.094 |
| SkinSen | 0.317 |
| Carcinogencity | 0.069 |
| EI | 0.224 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.931782 |